These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1010248)
1. [A study of the mechanism of the action of Bunaphtine recording the myocardial monophasic action potentials in man. Conclusive report (author's transl)]. Bonatti V; Finardi A; Cabasson J; Botti G G Ital Cardiol; 1976; 6(8):1378-83. PubMed ID: 1010248 [TBL] [Abstract][Full Text] [Related]
2. [Effects of Bunaphtine on right atrial and ventricular monophasic action potentials in man. Preliminary note (author's transl)]. Bonatti V; Finardi A; Cabasson J; Botti G G Ital Cardiol; 1976; 6(3):440-9. PubMed ID: 1010195 [TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic evaluation of intravenous bunaphtine in man. Di Biase M; Scarcia A; Chiddo A; Nacci E; Favale S; Rizzon P Acta Cardiol; 1977; 32(2):105-20. PubMed ID: 302072 [TBL] [Abstract][Full Text] [Related]
4. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
5. [Clinical value of monophasic action potentials]. Franz MR Z Kardiol; 1991 Apr; 80(4):241-9. PubMed ID: 1862664 [TBL] [Abstract][Full Text] [Related]
6. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus]. Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374 [No Abstract] [Full Text] [Related]
7. Effect of bunaphtine on right atrial repolarisation in man. Fenici R; Marchei M; Bellocci F; Zecchi P Br Heart J; 1977 Jul; 39(7):787-94. PubMed ID: 328029 [No Abstract] [Full Text] [Related]
8. [Correlations between plasmatic concentrations and antiarrhythmic effect of bunaphtine (author's transl)]. Rossi P; Carcano G; Rognoni G; Cernigliaro C; Calcaterra G G Ital Cardiol; 1976; 6(6):1048-55. PubMed ID: 1022605 [TBL] [Abstract][Full Text] [Related]
9. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence. Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078 [TBL] [Abstract][Full Text] [Related]
10. [Recording of the right atrial monophasic action potential in humans. I. Subjects not affected by arrhythmia]. Fenici R; Spirito F; Marchei M; Colonna P; Bellocci F G Ital Cardiol; 1978 Jun; 8(6):601-11. PubMed ID: 669116 [TBL] [Abstract][Full Text] [Related]
11. Class III antiarrhythmic action linked with positive inotropy: antiarrhythmic, electrophysiological, and hemodynamic effects of the sea-anemone polypeptide ATX II in the dog heart in situ. Platou ES; Refsum H; Hotvedt R J Cardiovasc Pharmacol; 1986; 8(3):459-65. PubMed ID: 2425158 [TBL] [Abstract][Full Text] [Related]
12. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo. Costard-Jäckle A; Franz MR J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468 [TBL] [Abstract][Full Text] [Related]
13. [Study of monophasic action potentials of the myocardium by endocavitary approach. Methodology]. Puech P; Cabasson J; Latour H; Grolleau R; Baissus C; Mellet JM Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1117-22. PubMed ID: 4218726 [TBL] [Abstract][Full Text] [Related]
14. [Blood bunaphthine during dynamic physical exercise and anti-arrhythmic action]. Rossi P; Cernigliaro C; Rognoni G; Carcano G G Ital Cardiol; 1976; 6(7):1233-7. PubMed ID: 64374 [TBL] [Abstract][Full Text] [Related]
15. Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview. Dorian P; Newman D Europace; 2000 Oct; 2(4):277-85. PubMed ID: 11194593 [TBL] [Abstract][Full Text] [Related]
16. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)]. Diewitz M Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986 [No Abstract] [Full Text] [Related]
17. [Recording of monophasic action potentials using a contact catheter in humans. Preliminary report]. Vojácek J; Slavícek J; Novák M; Psenicka M; Humhal J; Krupicka P Vnitr Lek; 1990 Oct; 36(10):951-7. PubMed ID: 2256256 [TBL] [Abstract][Full Text] [Related]
18. [The anti-arrhythmia properties of ketamine. Preliminary observations on the electrophysiological effects of the drug in humans by means of registration of right atrial monophasic action potentials and the His bundle electrogram]. Fenici R; Schiavello R; Marchei M Minerva Anestesiol; 1977 Sep; 43(9):487-93. PubMed ID: 927669 [No Abstract] [Full Text] [Related]
19. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His]. Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451 [No Abstract] [Full Text] [Related]
20. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects]. Steinbeck G Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]